Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer.
Sohal DP, Metz JM, Sun W, Giantonio BJ, Plastaras JP, Ginsberg G, Kochman ML, Teitelbaum UR, Harlacker K, Heitjan DF, Feldman MD, Drebin JA, O'Dwyer PJ. Sohal DP, et al. Cancer Chemother Pharmacol. 2013 Jun;71(6):1485-91. doi: 10.1007/s00280-013-2147-4. Epub 2013 Mar 27. Cancer Chemother Pharmacol. 2013. PMID: 23532207 Clinical Trial.
Radiation recall myositis: two sites, one patient.
Grover S, Jones JA, Teitelbaum U, Apisarnthanarax S. Grover S, et al. Among authors: teitelbaum u. Pract Radiat Oncol. 2015 Jan-Feb;5(1):39-42. doi: 10.1016/j.prro.2014.03.009. Epub 2014 May 5. Pract Radiat Oncol. 2015. PMID: 25413426 No abstract available.
Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma.
Boimel PJ, Berman AT, Li J, Apisarnthanarax S, Both S, Lelionis K, Larson GL, Teitelbaum U, Lukens JN, Ben-Josef E, Metz JM, Plastaras JP. Boimel PJ, et al. Among authors: teitelbaum u. J Gastrointest Oncol. 2017 Aug;8(4):665-674. doi: 10.21037/jgo.2017.03.04. J Gastrointest Oncol. 2017. PMID: 28890817 Free PMC article.
A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer.
Shabason JE, Chen J, Apisarnthanarax S, Damjanov N, Giantonio B, Loaiza-Bonilla A, O'Dwyer PJ, O'Hara M, Reiss KA, Teitelbaum U, Wissel P, Drebin JA, Vollmer C, Kochman M, Mick R, Vergara N, Jhala N, Doucette A, Lukens JN, Plastaras JP, Metz JM, Ben-Josef E. Shabason JE, et al. Among authors: teitelbaum u. Cancer Chemother Pharmacol. 2018 Mar;81(3):609-614. doi: 10.1007/s00280-018-3519-6. Epub 2018 Jan 23. Cancer Chemother Pharmacol. 2018. PMID: 29362902 Clinical Trial.
Quantifying the impact of the COVID-19 pandemic on gastrointestinal cancer care delivery.
Perkons NR, Kim C, Boedec C, Keele LJ, Schneider C, Teitelbaum UR, Ben-Josef E, Gabriel PE, Plastaras JP, Shulman LN, Wojcieszynski AP. Perkons NR, et al. Among authors: teitelbaum ur. Cancer Rep (Hoboken). 2022 Jan;5(1):e1427. doi: 10.1002/cnr2.1427. Epub 2021 Jun 17. Cancer Rep (Hoboken). 2022. PMID: 34137216 Free PMC article.
Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer.
Arscott WT, Nead KT, Bear A, Venigalla S, Shabason J, Lukens JN, Plastaras JP, Wojcieszynski A, Metz J, O'Hara M, Reiss KA, Teitelbaum U, Loaiza-Bonilla A, Drebin J, Lee MK 4th, Shroff SG, Ben-Josef E. Arscott WT, et al. Among authors: teitelbaum u. Am J Clin Oncol. 2021 Sep 1;44(9):469-474. doi: 10.1097/COC.0000000000000854. Am J Clin Oncol. 2021. PMID: 34310350 Free PMC article. Clinical Trial.
37 results